Table 5.

Saliva flow rates reported in the included studies (data presented as medians with interquartile range or min–max).

Study	AITD Diagnosis	Type of Saliva	Saliva Flow Rate (mL/min)
			Study Group	Control Group	p-Value
Ford et al., 1997 [24]	GD	Stimulated	1.4 (0.3–3.7)	1.2 (0.02–4.5)	<0.05
Morawska et al., 2021 [26]	HT	Unstimulated	0.27 (0.1–0.61)	0.67 (0.46–0.89)	<0.0001
Morawska et al., 2020 [27]	HT	Unstimulated	0.32 (0.07–0.77)	0.51 (0.27–0.96)	0.02
		Stimulated	0.90 (0.20–2.00)	1.01 (0.90–2.00)	ns
Agha-Hosseini et al., 2016 [32]	HT	Unstimulated	1.25 (0.90)	2.00 (2.14)	0.018
		Stimulated	2.87 (3.29)	3.50 (3.37)	0.470

Legend: AITD, autoimmune thyroid disease; GD, Graves’ disease; HT, Hashimoto’s thyroiditis; ns, not significant.